1. CDK1-PDK1-PI3K/Akt signaling pathway regulates embryonic and induced pluripotency
   Xiao Qi Wang et al, 2017, Cell Death & Differentiation CrossRef
2. Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities
   Hanchu Xiong et al, 2017, Oncotarget CrossRef
3. RNA binding proteins in cancer chemotherapeutic drug resistance
   Hemanathan Vembuli et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
4. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation
   Feng Ni et al, 2018, Cancer Chemotherapy and Pharmacology CrossRef
5. Lin28 and let-7: roles and regulation in liver diseases
   Kelly McDaniel et al, 2016, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
6. Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancer
   Tianzhen Wang et al, 2015, Molecular Cancer CrossRef
7. The LIN28/let-7 Pathway in Cancer
   Julien Balzeau et al, 2017, Frontiers in Genetics CrossRef
8. ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
   Weiqian Chen et al, 2020, Frontiers in Molecular Biosciences CrossRef
9. Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
   Man Xiao et al, 2017, Journal of Ovarian Research CrossRef
10. Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy
    C. Mir et al, 2022, Seminars in Cancer Biology CrossRef
11. LIN28B promotes the development of neuroendocrine prostate cancer
    Jessica Lovnicki et al, 2020, Journal of Clinical Investigation CrossRef
12. Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells
    Mingjie Zhou et al, 2015, Journal of Receptors and Signal Transduction CrossRef
13. Lin28A enhances chemosensitivity of colon cancer cells to 5-FU by promoting apoptosis in a let-7 independent manner
    Tianzhen Wang et al, 2016, Tumor Biology CrossRef
14. LIN28A inhibits lysosome‑associated membrane glycoprotein 1 protein expression in embryonic stem and bladder cancer cells
    Peng Pan et al, 2018, Molecular Medicine Reports CrossRef
15. Research progress on RNA‑binding proteins in breast cancer (Review)
    Wenzhu Zhang et al, 2022, Oncology Letters CrossRef
16. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review
    Yoshiaki Mizuguchi et al, 2016, Hepatology Research CrossRef
17. Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit
    Donatella Paola Provvisiero et al, 2019, Scientific Reports CrossRef
18. Lin28: an emerging important oncogene connecting several aspects of cancer
    Hao Wang et al, 2016, Tumor Biology CrossRef
19. Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma
    Evangelista Sagnelli et al, 2018, World Journal of Hepatology CrossRef
20. Dissimilar Appearances Are Deceptive–Common microRNAs and Therapeutic Strategies in Liver Cancer and Melanoma
    Lisa Linck-Paulus et al, 2020, Cells CrossRef
21. Selective inhibition of HDAC6 by N-acylhydrazone derivative reduces the proliferation and induces senescence in carcinoma hepatocellular cells
    Guilherme Álvaro Ferreira-Silva et al, 2024, Toxicology in Vitro CrossRef
22. Drug Resistance in Hepatocellular Carcinoma
    Xinxin Chen et al, 2023, Hepatobiliary Cancers: An Interdisciplinary Approach CrossRef